DUBLIN, May 26, 2022 /PRNewswire/ — The “Point-of-Care, Biosensors and Mobile Diagnostics Europe 2022” conference has been added to ResearchAndMarkets.com’s offering.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.
The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Emphasis will be placed on mobile diagnostics platforms and convergence with microfluidics-based and lab-on-a-chip approaches.
Point-of-Care, Biosensors & Mobile Diagnostics Europe 2022 to be held on-site as a standard physical conference at the Hilton Rotterdam brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Biosensors fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
Agenda:
Speakers
Keynote Speakers
Holger Schmidt
Narinder Kapany Professor of Electrical Engineering, University of California-Santa Cruz
Marloes Peeters
Deputy Director of Chemical Engineering, Newcastle University
Arben Merkoci
ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Catala de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST)
Karolien De Wael
Full Professor, Antwerp University
For more information about this conference visit https://www.researchandmarkets.com/r/aygvcm
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…
VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a…
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…
The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…
July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…